Innovex International, Inc.
INVX· NYSE
INVXInnovex International, Inc.
Filed Mar 1, 2023 · 10-K · 60 days after period end · 0000950170-23-005506
derived · Computed from the longer spans the company filed.
| Metric | Q4 2022dderived from reported figures | Q4 2021dderived from reported figures | Q4 2020 | Q4 2019 |
|---|---|---|---|---|
| Revenue | $233.52M | $68.08M | $87.23M | $108.45M |
| Net Income | $64.50M | -$63.93M | -$11.25M | $7.40M |
| EPS Diluted | — | — | -$0.33 | $0.21 |
Innovex International, Inc. · CIK 1042893 · Engraved from SEC EDGAR
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
ended Dec 31, 2022 · filed Mar 1, 2023 · 60 d after period end
